The cornerstone anti-aging strategy of suppressing insulin-like growth factor-1 signaling may be worthless if your cellular powerhouses are compromised. This finding challenges a fundamental assumption about longevity interventions and suggests that mitochondrial health takes priority in the aging hierarchy. Researchers tested IGF-1 suppression in mice engineered with unstable mitochondrial DNA, mimicking the mitochondrial deterioration that occurs naturally with age. The mutator mice accumulated DNA errors in their mitochondria at an accelerated rate, similar to what happens in normal aging but compressed into a shorter timeframe. When IGF-1 signaling was reduced in these mice—a manipulation that consistently extends lifespan in normal animals—the longevity benefit disappeared entirely. The cellular machinery that typically responds to IGF-1 suppression by activating protective pathways was either completely blocked or severely diminished when mitochondrial genomes were unstable. This represents a significant departure from decades of longevity research focused on IGF-1 as a master regulator of aging. The hierarchy revealed here suggests that mitochondrial genome integrity serves as a prerequisite for other anti-aging mechanisms to function effectively. For the growing number of adults experimenting with IGF-1-reducing strategies like intermittent fasting, growth hormone suppression, or caloric restriction, this research introduces an important caveat. These interventions may provide diminishing returns—or no benefit at all—in individuals whose mitochondrial function has already declined substantially. The study reinforces emerging evidence that mitochondrial health should be prioritized in longevity protocols, potentially through targeted antioxidants, exercise regimens that promote mitochondrial biogenesis, or direct mitochondrial genome protection strategies before attempting downstream interventions.